Skip to content

Treatment interruption 'safe' in those with lowest-ever CD4 counts above 250 cells/mm3

PEPFAR: US is tackling HIV drug supply in wrong way, say Christian hospitals

Nevirapine effect on 'good' cholesterol outranks efavirenz or statins, 2NN study reports

TB treatment: four month continuation phase better than six months

Risk factors for thrombosis in HIV-positive HAART treated patients studied

Modest weight and muscle gains seen with HAART

French study finds older patients are diagnosed later and have slower immune reconstitution

Two-thirds of PI-experienced children fail on lopinavir and accumulate resistance mutations

HAART reduces risk of death or new AIDS in HIV patients with TB